Literature DB >> 13679378

The RuvAB branch migration complex can displace topoisomerase IV.quinolone.DNA ternary complexes.

Molly E Shea1, Hiroshi Hiasa.   

Abstract

Quinolone antimicrobial drugs target both DNA gyrase and topoisomerase IV (Topo IV) and convert these essential enzymes into cellular poisons. Topoisomerase poisoning results in the inhibition of DNA replication and the generation of double-strand breaks. Double-strand breaks are repaired by homologous recombination. Here, we have investigated the interaction between the RuvAB branch migration complex and the Topo IV.quinolone.DNA ternary complex. A strand-displacement assay is employed to assess the helicase activity of the RuvAB complex in vitro. RuvAB-catalyzed strand displacement requires both RuvA and RuvB proteins, and it is stimulated by a 3'-non-hybridized tail. Interestingly, Topo IV.quinolone.DNA ternary complexes do not inhibit the translocation of the RuvAB complex. In fact, Topo IV.quinolone.DNA ternary complexes are reversed and displaced from the DNA upon their collisions with the RuvAB complex. These results suggest that the RuvAB branch migration complex can actively remove quinolone-induced covalent topoisomerase.DNA complexes from DNA and complete the homologous recombination process in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679378     DOI: 10.1074/jbc.M304217200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Quinolone-mediated bacterial death.

Authors:  Karl Drlica; Muhammad Malik; Robert J Kerns; Xilin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

2.  Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.

Authors:  Jean-Philippe Didier; Régis Villet; Elzbieta Huggler; Daniel P Lew; David C Hooper; William L Kelley; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

3.  Involvement of Holliday junction resolvase in fluoroquinolone-mediated killing of Mycobacterium smegmatis.

Authors:  Quanxin Long; Qinglin Du; Tiwei Fu; Karl Drlica; Xilin Zhao; Jianping Xie
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

4.  Analysis of RuvABC and RecG involvement in the escherichia coli response to the covalent topoisomerase-DNA complex.

Authors:  Jeanette H Sutherland; Yuk-Ching Tse-Dinh
Journal:  J Bacteriol       Date:  2010-07-02       Impact factor: 3.490

5.  Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo.

Authors:  Jennifer Reineke Pohlhaus; Kenneth N Kreuzer
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

6.  Repair and antirepair DNA helicases in Helicobacter pylori.

Authors:  Josephine Kang; Martin J Blaser
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

7.  Inhibition of mutation and combating the evolution of antibiotic resistance.

Authors:  Ryan T Cirz; Jodie K Chin; David R Andes; Valérie de Crécy-Lagard; William A Craig; Floyd E Romesberg
Journal:  PLoS Biol       Date:  2005-05-10       Impact factor: 8.029

Review 8.  Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.

Authors:  Natassja G Bush; Isabel Diez-Santos; Lauren R Abbott; Anthony Maxwell
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

Review 9.  Quinolones: action and resistance updated.

Authors:  Karl Drlica; Hiroshi Hiasa; Robert Kerns; Muhammad Malik; Arkady Mustaev; Xilin Zhao
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.